Fig. 3.
Fig. 3. Progressive tumor growth in nonimmune versus Id-immune mice challenged with BCL1 tumor cells. (A) The spleens from naive (○) and Id-immune (•) BALB/c mice injected with 106 BCL1 cells were palpated as described11 on the days indicated. Naive mice have an average spleen size of ∼0.5. Immunization with BCL1 Id results in a spleen size of 1 to 1.5 before BCL1 tumor injection. (B) BCL1 cells (1 × 106) were injected into naive BALB/c mice (○) or into Id-immune BALB/c mice (•). At the times indicated, mice were killed and the number of BCL1 tumor cells was determined by staining with RtABCL1Id for naive animals or RtAMλ for Id-immune animals (endogenous mouse anti-BCL1 Id [MA BCL1 Id] blocks staining with RtABCL1-Id but not the RtAMλ Ab) and analyzed by FACS.

Progressive tumor growth in nonimmune versus Id-immune mice challenged with BCL1 tumor cells. (A) The spleens from naive (○) and Id-immune (•) BALB/c mice injected with 106 BCL1 cells were palpated as described11 on the days indicated. Naive mice have an average spleen size of ∼0.5. Immunization with BCL1 Id results in a spleen size of 1 to 1.5 before BCL1 tumor injection. (B) BCL1 cells (1 × 106) were injected into naive BALB/c mice (○) or into Id-immune BALB/c mice (•). At the times indicated, mice were killed and the number of BCL1 tumor cells was determined by staining with RtABCL1Id for naive animals or RtAMλ for Id-immune animals (endogenous mouse anti-BCL1 Id [MA BCL1 Id] blocks staining with RtABCL1-Id but not the RtAMλ Ab) and analyzed by FACS.

Close Modal

or Create an Account

Close Modal
Close Modal